Other Event

Other Event

Other Adverse Events are non-serious adverse events that exceed a specific frequency threshold (typically 5% within any study arm). These events are reported to provide comprehensive safety information about all noteworthy adverse occurrences during clinical trials. Each other event is categorized by term, organ system, assessment type, and source vocabulary for standardized reporting.

Other Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Other Event

Study -> Results Section -> Adverse Events Module -> Other Event -> Other Event Stats

Other Event


Ignite Creation Date: 2025-12-25 @ 3:36 AM
Ignite Modification Date: 2025-12-26 @ 2:20 AM
NCT ID: NCT00861705
Term: Insomnia
Organ System: Psychiatric disorders
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: MedDRA 6
Notes: None
Study: NCT00861705
Study Brief: Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
Other Event Stats (If Any):

Other Event Stats

Group ID # Events # Affected # At Risk View
EG000 72 34 108 View
EG001 53 32 108 View
EG002 37 21 109 View
EG003 57 30 112 View